DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Dactinomycin

Dactinomycin

  • Anticancer Drug Discovery from Microbial Sources: the Unique Mangrove Streptomycetes

    Anticancer Drug Discovery from Microbial Sources: the Unique Mangrove Streptomycetes

  • Cytostatics As Hazardous Chemicals in Healthcare

    Cytostatics As Hazardous Chemicals in Healthcare

  • BC Cancer Benefit Drug List September 2021

    BC Cancer Benefit Drug List September 2021

  • Persistent Gestational Trophoblastic Disease Is Potentially Fatal, but the Majority of Patients Are Cured with Chemotherapy

    Persistent Gestational Trophoblastic Disease Is Potentially Fatal, but the Majority of Patients Are Cured with Chemotherapy

  • Dactinomycin

    Dactinomycin

  • Dactinomycin for INJECTION, USP

    Dactinomycin for INJECTION, USP

  • Pharmaceuticals As Environmental Contaminants

    Pharmaceuticals As Environmental Contaminants

  • Process for Producing Arsenic Trioxide Formulations

    Process for Producing Arsenic Trioxide Formulations

  • WILMS TUMOUR PI Wilms-1 Protocol

    WILMS TUMOUR PI Wilms-1 Protocol

  • EP/EMA Therapy (Etoposide Cisplatin/Etoposide Methotrexate Dactinomycin)

    EP/EMA Therapy (Etoposide Cisplatin/Etoposide Methotrexate Dactinomycin)

  • Standard Oncology Criteria C16154-A

    Standard Oncology Criteria C16154-A

  • Phase I/II Study of the Mesothelin-Targeted Immunotoxin LMB-100 with Nab-Paclitaxel For

    Phase I/II Study of the Mesothelin-Targeted Immunotoxin LMB-100 with Nab-Paclitaxel For

  • CYTOTOXIC and NON-CYTOTOXIC HAZARDOUS MEDICATIONS

    CYTOTOXIC and NON-CYTOTOXIC HAZARDOUS MEDICATIONS

  • Dactinomycin for Injection) (Actinomycin D

    Dactinomycin for Injection) (Actinomycin D

  • (12) United States Patent (10) Patent No.: US 8,273,379 B2 Warrell, Jr

    (12) United States Patent (10) Patent No.: US 8,273,379 B2 Warrell, Jr

  • Antitumor Antibiotics

    Antitumor Antibiotics

  • 6. Radiation Recall

    6. Radiation Recall

  • EMA/CO Therapy (Etoposide, Methotrexate, Dactinomycin, Cyclophosphamide, Vincristine)

    EMA/CO Therapy (Etoposide, Methotrexate, Dactinomycin, Cyclophosphamide, Vincristine)

Top View
  • 2012 NIOSH List of Antineoplastic and Other Hazardous Drugs
  • Pharmacokinetics of Dactinomycin in a Pediatric Patient Population: a United Kingdom Children’S Cancer Study Group Study Gareth J
  • BC Cancer Protocol Summary for Adjuvant Therapy for Rhabdomyosarcoma Using Vincristine, Dactinomycin, and Cyclophosphamide
  • GOTDMR Protocol
  • VACA (Vincristine Dactinomycin Doxorubicin Cyclophosphamide)
  • Chemotherapy Extravasation Management
  • 2019 Table of Drugs
  • Types of DRUGS ACTING on DNA (In Chapter 9) Intercalating Agents
  • Safe Handling of Hazardous Chemotherapy Drugs in Limited-Resource Settings
  • How to Order Chemotherapy at Shands at the University of Florida - Inpatient
  • Vincristine, Dactinomycin, Cyclophosphamide
  • COSMEGEN (Dactinomycin) MB1904
  • Dactinomycin-D Richard J. Cardosi, MD, FACOG
  • Management of Gestational Trophoblastic Neoplasia Ansar Hussain*, Shiekh Aejaz Aziz, Gul Mohd
  • Management of Extravasation of a Systemic Anti-Cancer Therapy Including Cytotoxic Agents
  • Handling Cytostatic Drugs: Contents
  • Update in Cancer Chemotherapy: Genitourinary Tract Cancer, Part 4: Testicular Cancer
  • Dactinomycin Induces Complete Remission Associated with Nucleolar Stress Response in Relapsed/Refractory NPM1-Mutated AML


© 2024 Docslib.org    Feedback